Curaleaf files Aurora bid variation with regulators
Curaleaf Holdings (TSECURA, OTCMKTSCURLF) filed an amendment with regulators to revise its takeover offer for Aurora Cannabis (TSEACB, NASDAQACB), extending the expiry date to Dec. 4 and adjusting the consideration. The revised offer implies US$5 per Aurora share, based on Curaleaf's share price on Oct. 2. Aurora's board is reviewing the materials and has not yet made a recommendation.
How this was made

The 30-second read
Why it matters
The amendment introduces new valuation metrics and extends the decision window, creating trading opportunities for both CUR and ACB.TO.
Market read
First report of a bid variation in a cross‑border cannabis M&A, affecting both stocks and the sector.
What to watch
Regulatory approvals in the U.S. and Canada could delay or block the transaction, affecting both stocks.
Background
Curaleaf, a U.S.-listed cannabis operator, is pursuing a cash‑and‑stock acquisition of Aurora Cannabis, a Canadian‑listed peer. The latest amendment adjusts the offer price and extends the tender deadline.
Market effects
The cannabis sector may see heightened M&A activity and valuation reassessment.
North American cannabis stocks could experience volatility as the deal progresses.
Limited to investors focused on cannabis and biotech M&A.
Counterpoint
If the bid extension signals weakness, investors might short Aurora ahead of a potential deal collapse.
Key entities
- CompanyCuraleaf Holdings, Inc.
U.S. cannabis operator filing the bid variation.
- CompanyAurora Cannabis Inc.
Canadian cannabis target of the takeover bid.
